IVF.
The longest cycle.

Fertility marketing fails when it treats hope like a click.

Why generic healthcare marketing fails for IVF

Fertility patients are not generic healthcare patients. They are couples — typically navigating the decision together — who have spent months or years trying to conceive before they consider IVF, who fact-check every clinic obsessively, who weigh emotional comfort with the doctor as heavily as success rates, and who often book based on a single YouTube video where the embryologist explained their case clearly.

A fertility marketing programme that uses the same playbook as primary care or cosmetic surgery underperforms on every meaningful metric. Patients click the ad but don't book. They book the consultation but don't return for treatment. They return for treatment but choose a different clinic for their second cycle. Each leak in this funnel costs ₹85K-₹220K in lost revenue. We've worked across this industry long enough to know what compounds: doctor personal brand, long-cycle nurture, transparent compliance with ASCI's success-rate guidelines, and a trust stack that respects the patient's emotional state.

What we ship for IVF engagements

The standard 18-month IVF programme builds: SEO across 240+ fertility query clusters (ICSI, IUI, donor egg programmes, surrogacy, PGT-A, recurrent miscarriage, fertility preservation, AMH testing); paid acquisition focused on cost-intent and competitor-brand keywords; personal brand programmes for the top 3-5 reproductive endocrinologists and embryologists; long-cycle CRM with 60-180-day email and WhatsApp nurture sequences; ASCI-compliant patient testimonial video; and where applicable, international intake funnels for cross-border IVF patients flying in from Bangladesh, Nepal, GCC, and East Africa.

The trust layer is decisive. Fertility content that includes peer-reviewed citations, named medical-board membership of the senior team, transparent fee schedules, and case-stratified success-rate disclosures consistently outperforms aspirational marketing copy. Patients in this category have read enough fertility forums to spot performative content immediately.

Compliance reality

IVF advertising in India operates under multiple frameworks: the MTP Act, the PCPNDT Act (which strictly prohibits sex determination), ASCI rules on healthcare advertising, and the Surrogacy (Regulation) Act 2021. Specific constraints: no advertising of sex determination services, no "100% success" claims, success rates if cited must use SART/ESHRE-aligned methodology with age-stratification (under 35, 35-37, 38-40, 41-42, over 42), patient testimonials must include "results not guaranteed; outcomes vary" disclosure, and donor or surrogate programmes have specific advertising prohibitions. We work with each clinic's medical director and legal team to ensure every published claim is defensible.

What good looks like in 12-18 months

After a full IVF engagement: 250-340% growth in monthly consultations, 60-70% reduction in cost-per-consultation versus baseline, top-3 organic ranking for ["IVF clinic city"] and the top 30 fertility queries in the geographic catchment, 8-15× growth in the top reproductive endocrinologist's combined social audience, and where international funnels are deployed, a measurable shift in cross-border patient inquiry volume.

Things ivf & fertility teams ask us first.

8 fertility files, indexed.

Other industries.